6/5/2007

Two Food and Drug Administration panels are scheduled to review the drug Tysabri in July as a possible treatment for Crohn's disease. Studies indicate the drug, approved to treat multiple sclerosis, is effective in preventing inflammatory immune cells from penetrating intestinal walls.

Full Story:
Forbes

Related Summaries